Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERSE trial of mifepristone for treatment-resistant PTSD
NL-OMON58819Phase 2Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in post-traumatic stress disorder (PTSD) comparing Mifepristone with Placebo (2 arms). Started Nov 2024; status: recruiting.
02
Drugs
mifepristone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON58819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58819.